Myasthenia Gravis Trial, Recruiting (NCT04535843)

Myasthenia Gravis Trial, Recruiting NCT04535843 Sponsor: Huashan Hospital Condition: Myasthenia Gravis

Printed from Voxsanity (voxsanity.com.au) — NCT04535843 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Myasthenia Gravis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have muscle weakness that comes and goes, along with tiredness in your muscles, plus at least one of the following:
A specific nerve test (called repetitive nerve stimulation) shows your muscles are responding in a particular abnormal way (confirm with trial site)
A blood test shows you have certain antibodies linked to muscle weakness (called anti-AChR or MuSK antibodies)
You had a positive response to a test using a medication called neostigmine
You are able to understand and sign the consent form, and are willing and able to attend follow-up appointments

Who may not be able to join:

You have been diagnosed with, or are suspected to have, certain other conditions that can cause similar symptoms — such as Lambert-Eaton syndrome, congenital myasthenia syndrome, botulism, or a condition affecting eye muscle movement called chronic progressive external ophthalmoplegia (confirm with trial site for the full list)
You are unlikely or unable to attend follow-up appointments as required by the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chongbo Zhao, MD, Huashan Hospital, Shanghai,China

Phone: 86-021-52889999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04535843

Sponsor: Huashan Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Myasthenia Gravis

Trial contact: 86-021-52889999

More information: https://clinicaltrials.gov/study/NCT04535843

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have muscle weakness that comes and goes, along with tiredness in your muscles, plus at least one of the following:
A specific nerve test (called repetitive nerve stimulation) shows your muscles are responding in a particular abnormal way (confirm with trial site)
A blood test shows you have certain antibodies linked to muscle weakness (called anti-AChR or MuSK antibodies)
You had a positive response to a test using a medication called neostigmine
You are able to understand and sign the consent form, and are willing and able to attend follow-up appointments

Who may not be able to join:

You have been diagnosed with, or are suspected to have, certain other conditions that can cause similar symptoms — such as Lambert-Eaton syndrome, congenital myasthenia syndrome, botulism, or a condition affecting eye muscle movement called chronic progressive external ophthalmoplegia (confirm with trial site for the full list)
You are unlikely or unable to attend follow-up appointments as required by the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Huashan Hospital

Registry

ClinicalTrials.gov

Start date

1 February 2024

Est. completion

1 February 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Myasthenia gravis foundation of America post intervention status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov